Cosmetic Compliance in United Kingdom
Full UK cosmetic compliance: CPSR, SCPN notification, Responsible Person services, and Product Information File management. Led by a Clinical Pharmacologist with University of Oxford credentials. 100% acceptance rate.
Regulatory framework
- Regulator
- OPSS (Office for Product Safety and Standards)
- Primary regulation
- UK Cosmetic Regulation 2013 (as retained and amended after EU exit)
- Notification
- SCPN (Submit Cosmetic Product Notification)
- Region
- Europe
Selling cosmetics in the United Kingdom
Since the UK left the EU, cosmetic products placed on the UK market are governed by retained UK Cosmetic Regulation, administered by the Office for Product Safety and Standards (OPSS). The regulatory framework remains closely aligned with EU Regulation 1223/2009, but notifications, Responsible Person requirements, and labelling now operate through UK-specific systems.
Three things must be in place before a single unit is sold:
- A valid Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor.
- A UK-based Responsible Person (RP) named on the product packaging.
- SCPN notification, the Submit Cosmetic Product Notification system that replaced the EU’s CPNP for UK sales.
Recent restrictions: the 2026 chemicals programme
UK and EU rules now diverge not only in process but in substance, and 2026 is the clearest example. The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026 (SI 2026/23), laid before Parliament on 15 January 2026, makes three changes that affect products on the GB market:
- 4-Methylbenzylidene Camphor (4-MBC, enzacamene) is prohibited. The UV filter is removed from Annex VI and added to the Annex II list of prohibited substances, following a Scientific Advisory Group on Chemical Safety assessment that could not conclude it was safe. It may not be placed on the GB market from 15 July 2026, and existing stock may be made available only until 14 January 2027.
- Sixteen substances newly classified as carcinogenic, mutagenic or toxic for reproduction (categories 1B and 2) under the GB CLP Regulation are added to Annex II. They span several chemical families, including certain photoinitiators (Trimethylbenzoyl diphenylphosphine oxide, used in some nail products, among them), organotin compounds and industrial intermediates. Placement on the GB market ends 15 August 2026, with sell-through to 14 February 2027.
- Formaldehyde-releaser labelling is tightened sharply. The threshold that triggers the mandatory warning “releases formaldehyde” falls from 0.05 per cent to 0.001 per cent (10 ppm) of free formaldehyde in the finished product, a fifty-fold reduction that brings GB broadly into line with the approach the EU took under Commission Regulation (EU) 2022/1181. It applies to products placed on the market from 15 July 2026.
A second instrument, the (No. 2) Regulations 2026, follows behind it, adding further prohibited substances and an Annex III restriction on hexyl salicylate, with its own staggered dates running into 2027. The full list of substances prohibited by SI 2026/23, with CAS numbers, is set out in our SI 2026/23 reference.
These are GB-specific obligations. SI 2026/23 amends the assimilated UK Regulation, not the EU one, and its dates and thresholds are set independently of Brussels. For a brand selling into both markets the practical task is a substance-by-substance check of the formulation against the GB and EU annexes separately, which is part of our Responsible Person service and the work behind a UK CPSR. (Position as at June 2026; confirm the current OPSS position before relying on these dates.)
Cosmetic Product Safety Reports for the UK
Oxford Biosciences CPSRs are led by our Clinical Pharmacologist, who holds an MSc with Distinction in Experimental Therapeutics and Clinical Pharmacology from the University of Oxford. Every assessment is reviewed against UK Cosmetic Regulation Annexes I-VIII, calculating exposure, toxicological risk, and cumulative impact for each ingredient.
Once the full documentation set is supplied, standard turnaround is typically 2 to 3 working days. A 48-hour service is available at a 50 per cent premium and a 24-hour service at a 100 per cent premium. The standard CPSR is £220 for a single product of up to 20 ingredients, with single-ingredient reports from £70.
How Oxford Biosciences supports UK market entry
We act as a single point of contact across every step: CPSR, TRA, RP services, SCPN submission, PIF management, ongoing post-market surveillance, and adverse event reporting. Our name goes on your packaging as RP, which means our reputation is staked on the integrity of every product we certify.
Pricing and turnaround
| Service | From | Turnaround |
|---|---|---|
| CPSR (single product, up to 20 ingredients) | £220 | 2 to 3 days |
| CPSR (single ingredient) | £70 | 2 to 3 days |
| Responsible Person, UK and EU (Year 1, per product) | £299 (£149 net of credit) | Within regulated timeframes |
| SCPN notification | Included with RP | Within regulated timeframes |
| Label review | £195 | From receipt of artwork |
Our services for United Kingdom
CPSR
From £70 · 2 to 3 days
The Cosmetic Product Safety Report is the safety assessment required under Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product may be placed on the UK or EU market. Prepared and signed by a qualified safety assessor.
Learn more →Responsible Person
From £149 · per product, per year
Oxford Biosciences acts as your Responsible Person in the UK and the EU under a single quality management system, holding the regulatory obligation: PIF maintenance, SCPN and CPNP notification, labelling oversight, and cosmetovigilance.
Learn more →Labelling
From £195 · from receipt of artwork
Independent review of packaging artwork against Article 19, and of product claims against the six Common Criteria of Regulation (EU) 655/2013. Label review £195; per-claim review from £125; substantiation dossiers from £1,495.
Learn more →Testing
From £75
Stability, microbiology, photoprotection and analytical testing carried out in our three in-house laboratories. Analytical work is not contracted out; results pass directly to the assessor preparing your CPSR.
Learn more →Frequently asked questions
What is SCPN?
SCPN, the Submit Cosmetic Product Notification service, is the UK government system through which cosmetic products are notified before being placed on the Great Britain market. It replaced reliance on the EU's CPNP for GB after Brexit. Notification is made by the UK Responsible Person and is overseen by the Office for Product Safety and Standards (OPSS). A product should be notified only once it has been assessed as safe. Oxford Biosciences manages SCPN notification as part of its UK Responsible Person service.
What are the UK Responsible Person requirements?
To sell a cosmetic product in Great Britain you must appoint a UK Responsible Person established in the UK, who takes legal responsibility for compliance, holds the Product Information File, and notifies the product through the SCPN service to the Office for Product Safety and Standards. Since 1 January 2026 the UK Responsible Person's name and address must appear on the product label for goods placed on the GB market. Oxford Biosciences acts as UK Responsible Person through Oxford Biosciences Ltd, and as EU Responsible Person through our Irish-registered entity, under a single quality management system.
How much does a UK CPSR cost?
A UK Cosmetic Product Safety Report from Oxford Biosciences is £220 for a single product of up to 20 ingredients, the same report that serves the EU market under Annex I of Regulation (EC) No 1223/2009. A single-ingredient product is £70, variants are £40, and batch pricing applies from £875 for five products. Once the full documentation set is supplied, turnaround is typically 2 to 3 working days, with 48-hour and 24-hour expedited service available. All fees are exclusive of VAT.
What do I need to sell cosmetics on Amazon UK?
Selling cosmetics on Amazon UK carries the same legal requirements as any Great Britain sale: a valid Cosmetic Product Safety Report, a UK-established Responsible Person, SCPN notification to the Office for Product Safety and Standards, and compliant labelling, including the UK Responsible Person's details on the label since 1 January 2026. Marketplaces increasingly ask sellers to evidence this documentation. Oxford Biosciences provides the CPSR, acts as your UK Responsible Person, and manages the SCPN notification so your listings meet the requirement.